Skip to main content

Advertisement

Log in

Cutting Edge Issues in Autoimmunity

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Anderson GP (2006) Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol 31:119–130

    Article  PubMed  CAS  Google Scholar 

  2. Anderson SD (2006) Beta(2)-Agonists: Introduction. Clin Rev Allergy Immunol 31:103–105

    Article  Google Scholar 

  3. Anderson SD, Caillaud C, Brannan JD (2006) Beta2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol 31:163–180

    Article  PubMed  CAS  Google Scholar 

  4. Bohle B (2006) T-cell epitopes of food allergens. Clin Rev Allergy Immunol 30:97–108

    Article  PubMed  CAS  Google Scholar 

  5. Borchers AT, Chang C, Keen CL, Gershwin ME (2006) Airborne environmental injuries and human health. Clin Rev Allergy Immunol 31:1–101

    Article  PubMed  CAS  Google Scholar 

  6. Borish L, Rosenwasser L, Steinke JW (2006) Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt. Clin Rev Allergy Immunol 30:195–204

    Article  PubMed  CAS  Google Scholar 

  7. Bourrain JL (2006) Occupational contact urticaria. Clin Rev Allergy Immunol 30:39–46

    Article  PubMed  CAS  Google Scholar 

  8. Cockcroft DW (2006) Clinical concerns with inhaled beta2-agonists: adult asthma. Clin Rev Allergy Immunol 31:197–208

    Article  PubMed  CAS  Google Scholar 

  9. Cribier B (2006) Urticaria and hepatitis. Clin Rev Allergy Immunol 30:25–29

    Article  PubMed  Google Scholar 

  10. Doutre MS (2006) Chronic urticaria and thyroid auto-immunity. Clin Rev Allergy Immunol 30:31–37

    Article  PubMed  CAS  Google Scholar 

  11. Esch RE (2006) Allergens. Clin Rev Allergy Immunol 30:71–72

    Article  PubMed  CAS  Google Scholar 

  12. Fitch KD (2006) beta2-Agonists at the Olympic Games. Clin Rev Allergy Immunol 31:259–268

    Article  PubMed  CAS  Google Scholar 

  13. Grob JJ, Gaudy-Marqueste C (2006) Urticaria and quality of life. Clin Rev Allergy Immunol 30:47–51

    Article  PubMed  Google Scholar 

  14. Hancox RJ (2006) Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Clin Rev Allergy Immunol 31:279–288

    Article  PubMed  Google Scholar 

  15. Hancox RJ (2006) Interactions between corticosteroids and beta2-agonists. Clin Rev Allergy Immunol 31:231–246

    Article  PubMed  CAS  Google Scholar 

  16. Haney S, Hancox RJ (2006) Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 31:181–196

    Article  PubMed  CAS  Google Scholar 

  17. Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF (2006) Pathophysiology of urticaria. Clin Rev Allergy Immunol 30:3–11

    Article  PubMed  CAS  Google Scholar 

  18. Hoffman DR (2006) Hymenoptera venom allergens. Clin Rev Allergy Immunol 30:109–128

    Article  PubMed  CAS  Google Scholar 

  19. Kauffman HF (2006) Innate immune responses to environmental allergens. Clin Rev Allergy Immunol 30:129–140

    Article  PubMed  CAS  Google Scholar 

  20. Kong JS, Teuber S, Hallett R, Gershwin ME (2006) Mastocytosis: the great masquerader. Clin Rev Allergy Immunol 30:53–60

    Article  PubMed  Google Scholar 

  21. Kumar A, Teuber SS, Naguwa S, Prindiville T, Gershwin ME (2006) Eosinophilic gastroenteritis and citrus-induced urticaria. Clin Rev Allergy Immunol 30:61–70

    Article  PubMed  Google Scholar 

  22. Luong A, Marple BF (2006) Sinus surgery: indications and techniques. Clin Rev Allergy Immunol 30:217–222

    Article  PubMed  Google Scholar 

  23. Mafee MF, Tran BH, Chapa AR (2006) Imaging of rhinosinusitis and its complications: plain film, CT, and MRI. Clin Rev Allergy Immunol 30:165–186

    Article  PubMed  Google Scholar 

  24. Martinez FD (2006) Serious adverse events and death associated with treatment using long-acting beta-agonists. Clin Rev Allergy Immunol 31:269–278

    Article  PubMed  CAS  Google Scholar 

  25. Mathelier-Fusade P (2006) Drug-induced urticarias. Clin Rev Allergy Immunol 30:19–23

    Article  PubMed  CAS  Google Scholar 

  26. Page CP, Spina D (2006) Beta2-agonists and bronchial hyperresponsiveness. Clin Rev Allergy Immunol 31:143–162

    Article  PubMed  CAS  Google Scholar 

  27. Peachell P (2006) Regulation of mast cells by beta-agonists. Clin Rev Allergy Immunol 31:131–142

    Article  PubMed  CAS  Google Scholar 

  28. Ponikau JU, Sherris DA, Kephart GM, Adolphson C, Kita H (2006) The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol 30:187–194

    Article  PubMed  Google Scholar 

  29. Salpeter SR, Buckley NS (2006) Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Clin Rev Allergy Immunol 31:219–230

    Article  PubMed  CAS  Google Scholar 

  30. Schubert MS (2006) Allergic fungal sinusitis. Clin Rev Allergy Immunol 30:205–216

    Article  PubMed  Google Scholar 

  31. Slavin RG (2006) Introduction. Clin Rev Allergy Immunol 30:141–142

    Article  Google Scholar 

  32. Smart BA (2006) Is rhinosinusitis a cause of asthma. Clin Rev Allergy Immunol 30:153–164

    Article  PubMed  Google Scholar 

  33. Staumont-Salle D, Dombrowicz D, Capron M, Delaporte E (2006) Eosinophils and urticaria. Clin Rev Allergy Immunol 30:13–18

    Article  PubMed  CAS  Google Scholar 

  34. Subbarao P, Ratjen F (2006) Beta2-agonists for asthma: the pediatric perspective. Clin Rev Allergy Immunol 31:209–218

    Article  PubMed  CAS  Google Scholar 

  35. Tattersfield AE (2006) Current issues with beta2-adrenoceptor agonists: historical background. Clin Rev Allergy Immunol 31:107–118

    Article  PubMed  CAS  Google Scholar 

  36. Taylor DR (2006) Pharmacogenetics of beta2-agonist drugs in asthma. Clin Rev Allergy Immunol 31:247–258

    Article  PubMed  CAS  Google Scholar 

  37. Verdino P (2006) Structural characterization of pollen allergens. Clin Rev Allergy Immunol 30:73–95

    Article  PubMed  CAS  Google Scholar 

  38. Wald ER (2006) Beginning antibiotics for acute rhinosinusitis and choosing the right treatment. Clin Rev Allergy Immunol 30:143–152

    Article  PubMed  CAS  Google Scholar 

  39. Amigo MC (2007) The Heart and APS. Clin Rev Allergy Immunol 32:178–183

    Article  PubMed  Google Scholar 

  40. Asherson RA, Cervera R (2007) Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 32:153–158

    Article  PubMed  Google Scholar 

  41. Blank M, Barzilai O, Shoenfeld Y (2007) Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 32:111–118

    PubMed  Google Scholar 

  42. Borchers AT, Keen CL, Gershwin ME (2007) Smoking cessation: significance and implications for children. Clin Rev Allergy Immunol, In press

  43. Boren E, Teuber SS, Naguwa SM, Gershwin ME (2007) A critical review of local anesthetic sensitivity. Clin Rev Allergy Immunol 32:119–128

    PubMed  CAS  Google Scholar 

  44. Carp HJ, Shoenfeld Y (2007) Anti-phospholipid antibodies and infertility. Clin Rev Allergy Immunol 32:159–161

    Article  PubMed  CAS  Google Scholar 

  45. Goodarzi H, Trowbridge J, Gallo RL (2007) Innate immunity: a cutaneous perspective. Clin Rev Allergy Immunol, In press

  46. Gorshtein A, Levy Y (2007) Orthopedic involvement in antiphospholipid syndrome. Clin Rev Allergy Immunol 32:167–171

    Article  PubMed  Google Scholar 

  47. Guillevin L, Pagnoux C, Guilpain P, Bienvenu B, Martinez V, Mouthon L (2007) Indications for biotherapy in systemic vasculitides. Clin Rev Allergy Immunol 32:85–96

    Article  PubMed  Google Scholar 

  48. Hodak E, David M (2007) Primary anetoderma and antiphospholipid antibodies–review of the literature. Clin Rev Allergy Immunol 32:162–166

    Article  PubMed  Google Scholar 

  49. Hughes G (2007) Hughes Syndrome: the antiphospholipid syndrome–a clinical overview. Clin Rev Allergy Immunol 32:3–12

    PubMed  Google Scholar 

  50. Jara LJ, Medina G, Vera-Lastra O (2007) Systemic antiphospholipid syndrome and atherosclerosis. Clin Rev Allergy Immunol 32:172–177

    Article  PubMed  CAS  Google Scholar 

  51. Jonsson MV, Delaleu N, Jonsson R (2007) Animal Models of Sjogren's Syndrome. Clin Rev Allergy Immunol 32:215–224

    Article  PubMed  CAS  Google Scholar 

  52. Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T Lymphocytes in Sjogren's Syndrome: Contributors to and Regulators of Pathophysiology. Clin Rev Allergy Immunol 32:252–264

    Article  PubMed  CAS  Google Scholar 

  53. Kiss E, Shoenfeld Y (2007) Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus. Clin Rev Allergy Immunol 32:37–46

    PubMed  CAS  Google Scholar 

  54. Kong JS, Teuber SS, Gershwin ME (2007) Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Clin Rev Allergy Immunol 32:97–110

    PubMed  CAS  Google Scholar 

  55. Liberato B, Levy RA (2007) Antiphospholipid syndrome and cognition. Clin Rev Allergy Immunol 32:188–191

    Article  PubMed  CAS  Google Scholar 

  56. Maeurer M (2007) High-content T-cell and B-cell analysis. Clin Rev Allergy Immunol 32:75–84

    PubMed  CAS  Google Scholar 

  57. Manoussakis MN, Kapsogeorgou EK (2007) The Role of epithelial cells in the pathogenesis of Sjogren's syndrome. Clin Rev Allergy Immunol 32:225–230

    Article  PubMed  CAS  Google Scholar 

  58. Matthias T, Shoenfeld Y (2007) Cutting edge issues in allergy and clinical immunology. Clin Rev Allergy Immunol 32:1–2

    Article  PubMed  Google Scholar 

  59. Mavragani CP, Moutsopoulos HM (2007) Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol 32:284–291

    Article  PubMed  CAS  Google Scholar 

  60. Meijer JM, Pijpe J, Bootsma H, Vissink A, Kallenberg CG (2007) The future of biologic agents in the treatment of Sjogren's syndrome. Clin Rev Allergy Immunol 32:292–297

    Article  PubMed  CAS  Google Scholar 

  61. Meroni PL, Ronda N, De Angelis V, Grossi C, Raschi E, Borghi MO (2007) Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies. Clin Rev Allergy Immunol 32:67–74

    PubMed  CAS  Google Scholar 

  62. Moutsopoulos HM (2007) Sjogren's syndrome or autoimmune epithelitis. Clin Rev Allergy Immunol 32:199–200

    Article  PubMed  CAS  Google Scholar 

  63. Nichols D, Chmiel J, Berger M (2007) Chronic inflammation in the cystic fibrosis lung: Alterations in inter- and intracellular signaling. Clin Rev Allergy Immunol, In press

  64. Ramesh S (2007) Food allergy overview in children. Clin Rev Allergy Immunol, In press

  65. Ramos-Casals M, Brito-Zeron P, Font J (2007) Lessons from diseases mimicking Sjogren's syndrome. Clin Rev Allergy Immunol 32:275–283

    Article  PubMed  Google Scholar 

  66. Reinstein E, Shoenfeld Y (2007) Antiphospholipid syndrome and cancer. Clin Rev Allergy Immunol 32:184–187

    Article  PubMed  Google Scholar 

  67. Routsias JG, Tzioufas AG (2007) Sjogren's syndrome-study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 32:238–251

    Article  PubMed  CAS  Google Scholar 

  68. Shoenfeld Y (2007) APS–more systemic disease than SLE. Clin Rev Allergy Immunol 32:129–130

    Article  PubMed  Google Scholar 

  69. Shovman O, Gilburd B, Barzilai O, Langevitz P, Shoenfeld Y (2007) Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome. Clin Rev Allergy Immunol 32:145–152

    Article  PubMed  CAS  Google Scholar 

  70. Steiner G (2007) Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools. Clin Rev Allergy Immunol 32:23–36

    PubMed  CAS  Google Scholar 

  71. Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G et al (2007) Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up. Clin Rev Allergy Immunol 32:131–137

    Article  PubMed  CAS  Google Scholar 

  72. Toubi E, Shoenfeld Y (2007) Livedo reticularis as a criterion for antiphospholipid syndrome. Clin Rev Allergy Immunol 32:138–144

    Article  PubMed  CAS  Google Scholar 

  73. Triantafyllopoulou A, Moutsopoulos H (2007) Persistent viral infection in primary Sjogren's syndrome: review and perspectives. Clin Rev Allergy Immunol 32:210–214

    Article  PubMed  CAS  Google Scholar 

  74. Voulgarelis M, Skopouli FN (2007) Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol 32:265–274

    Article  PubMed  CAS  Google Scholar 

  75. Warger T, Rechtsteiner G, Schmid B, Osterloh P, Schild H, Radsak MP (2007) Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection. Clin Rev Allergy Immunol 32:57–66

    PubMed  Google Scholar 

  76. Welliver RC, Sr (2007) The immune response to respiratory syncytial virus infection: rriend or Foe? Clin Rev Allergy Immunol, In press

  77. Wiik AS (2007) The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects. Clin Rev Allergy Immunol 32:13–22

    PubMed  Google Scholar 

  78. Williams PH, Cobb BL, Namjou B, Scofield RH, Sawalha AH, Harley JB (2007) Horizons in Sjogren's syndrome genetics. Clin Rev Allergy Immunol 32:201–209

    Article  PubMed  CAS  Google Scholar 

  79. Wu R, Shovman O, Zhang Y, Gilburd B, Zandman-Goddard G, Shoenfeld Y (2007) Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin Rev Allergy Immunol 32:47–56

    PubMed  CAS  Google Scholar 

  80. Yehudai D, Shoenfeld Y, Toubi E (2007) Looking into the eyes of patients with antiphospholipid syndrome. Clin Rev Allergy Immunol 32:192–197

    Article  PubMed  CAS  Google Scholar 

  81. Youinou P, Devauchelle V, Hutin P, Le Berre R, Saraux A, Pers JO (2007) A conspicuous role for B cells in Sjogren's syndrome. Clin Rev Allergy Immunol 32:231–237

    Article  PubMed  CAS  Google Scholar 

  82. Abou-Raya A, Abou-Raya S (2006) Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5:331–337

    Article  PubMed  CAS  Google Scholar 

  83. Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y et al (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27:50–53

    Article  PubMed  CAS  Google Scholar 

  84. Asherson RA (2006) The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun Rev 6:64–67

    Article  PubMed  Google Scholar 

  85. Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME (2006) Juvenile idiopathic arthritis. Autoimmun Rev 5:279–298

    Article  PubMed  CAS  Google Scholar 

  86. Brandt D, Gershwin ME (2006) Common variable immune deficiency and autoimmunity. Autoimmun Rev 5:465–470

    Article  PubMed  CAS  Google Scholar 

  87. Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL et al (2006) Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 26:232–240

    Article  PubMed  CAS  Google Scholar 

  88. Damoiseaux JG, Tervaert JW (2006) From ANA to ENA: how to proceed. Autoimmun Rev 5:10–17

    Article  PubMed  CAS  Google Scholar 

  89. Denkberg G, Reiter Y (2006) Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation. Autoimmun Rev 5:252–257

    Article  PubMed  CAS  Google Scholar 

  90. Eisenlohr LC, Rothstein JL (2006) Oncogenic inflammation and autoimmune disease. Autoimmun Rev 6:107–114

    Article  PubMed  Google Scholar 

  91. Kong JS, Teuber SS, Gershwin ME (2006) Potential adverse events with biologic response modifiers. Autoimmun Rev 5:471–485

    Article  PubMed  CAS  Google Scholar 

  92. Okada T, Inaba M, Naiki M, Lian ZX, Gershwin ME, Ikehara S (2007) Comparative immunobiology of thymic DC mRNA in autoimmune-prone mice. J Autoimmun 28:41–45

    Article  PubMed  CAS  Google Scholar 

  93. Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS et al (2006) Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 27:7–16

    Article  PubMed  CAS  Google Scholar 

  94. Abbas AK, Lohr J, Knoechel B, Nagabhushanam V (2004) T cell tolerance and autoimmunity. Autoimmun Rev 3:471–475

    Article  PubMed  CAS  Google Scholar 

  95. Avrameas S, Ternynck T, Tsonis IA, Lymberi P (2007) Naturally occurring B-cell autoreactivity: A critical overview. J Autoimmun 29:213–218

    Article  PubMed  CAS  Google Scholar 

  96. Cohen IR (2007) Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29:246–249

    Article  PubMed  CAS  Google Scholar 

  97. Foreman AL, Van de Water J, Gougeon ML, Gershwin ME (2007) B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev 6:387–401

    Article  PubMed  CAS  Google Scholar 

  98. Gebe JA, Unrath KA, Yue BB, Miyake T, Falk BA, Nepom GT (2007) Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun, In press

  99. Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity. Autoimmun Rev 7:42–45

    Article  PubMed  CAS  Google Scholar 

  100. Lan RY, Mackay IR, Eric Gershwin M (2007) Regulatory T cells in the prevention of mucosal inflammatory diseases: Patrolling the border. J Autoimmun 29:272–280

    Article  PubMed  CAS  Google Scholar 

  101. Lang KS, Burow A, Kurrer M, Lang PA, Recher M (2007) The role of the innate immune response in autoimmune disease. J Autoimmun 29:206–212

    Article  PubMed  CAS  Google Scholar 

  102. Lleo A, Invernizzi P, Selmi C, Coppel RL, Alpini G, Podda M et al (2007) Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29:61–68

    Article  PubMed  CAS  Google Scholar 

  103. Lutz HU (2007) Homeostatic roles of naturally occurring antibodies: An overview. J Autoimmun 29:287–294

    Article  PubMed  CAS  Google Scholar 

  104. Mantovani A, Garlanda C, Locati M, Rodriguez TV, Feo SG, Savino B et al (2007) Regulatory pathways in inflammation. Autoimmun Rev 7:8–11

    Article  PubMed  CAS  Google Scholar 

  105. Milner J, Ward J, Keane-Myers A, Min B, Paul WE (2007) Repertoire-dependent immunopathology. J Autoimmun 29:257–261

    Article  PubMed  CAS  Google Scholar 

  106. Papadimitraki ED, Bertsias GK, Boumpas DT (2007) Toll like receptors and autoimmunity: A critical appraisal. J Autoimmun 29:310–318

    PubMed  CAS  Google Scholar 

  107. Pasquali JL, Soulas-Sprauel P, Korganow AS, Martin T (2007) Auto-reactive B cells in transgenic mice. J Autoimmun 29:250–256

    Article  PubMed  CAS  Google Scholar 

  108. Peng Y, Martin DA, Kenkel J, Zhang K, Ogden CA, Elkon KB (2007) Innate and adaptive immune response to apoptotic cells. J Autoimmun 29:303–309

    Article  PubMed  CAS  Google Scholar 

  109. Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR (2007) Autoreactive B-1 B cells: Constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29:236–245

    Article  PubMed  CAS  Google Scholar 

  110. Ryan KR, Patel SD, Stephens LA, Anderton SM (2007) Death, adaptation and regulation: The three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 29:262–271

    Article  PubMed  CAS  Google Scholar 

  111. Selmi C (2007) One year in autoimmunity. Autoimmun Rev 7:85–93

    Article  PubMed  CAS  Google Scholar 

  112. Shimada A, Kanazawa Y, Motohashi Y, Yamada S, Maruyama T, Ikegami H, et al (2007) Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun, In press

  113. Tsonis IA, Avrameas S, Moutsopoulos HM (2007) Autoimmunity and pathophysiology. J Autoimmun 29:203–205

    Article  PubMed  CAS  Google Scholar 

  114. Zelenay S, Moraes Fontes MF, Fesel C, Demengeot J, Coutinho A (2007) Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29:229–235

    Article  PubMed  CAS  Google Scholar 

  115. Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF et al (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27:232–241

    Article  PubMed  CAS  Google Scholar 

  116. Rieger R, Gershwin ME (2007) The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28:76–84

    Article  PubMed  CAS  Google Scholar 

  117. Pordeus V, Szyper-Kravitz M, Levy R, Vaz N, Shoenfeld Y (2007) Infections and autoimmunity: a panorama. Clin Rev Allergy Immunol, In press

  118. Rose N (2007) The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol, In press

  119. Meroni P, Gerosa M, Raschi E, Scurati S, Grossi C, Borghi M (2007) Updating on the pathogenic mechanisms of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol, In press

  120. Toubi E (2007) The role of CD4 + CD25 + T regulatory cells in autoimmune diseases. Clin Rev Allergy Immunol, In press

  121. Veldman C, Feliciani C (2007) Pemphigus: A complex T-cell dependent autoimmune disorder leading to acantholysis. Clin Rev Allergy Immunol, In press

  122. Appenzeller S, Pike G, Clarke A (2007) Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol, In press

  123. Blank M, Shoenfeld Y (2007) Histidine-rich glycoprotein modulation of immune/autoimmune, vascular and coagulation systems. Clin Rev Allergy Immunol, In press

  124. Coca A, Anolik J (2007) Targeted biologic approaches to the treatment of systemic vasculitis. Clin Rev Allergy Immunol, In press

  125. Csernok E, Moosig F, Gross W (2007) Pathways to ANCA production: from maturation of dendritic cells by proteinase 3 to B lymphocytes maturation in Wegener's granuloma. Clin Rev Allergy Immunol, In press

  126. Renaudineau Y, Dalekos G, Gueguen P, Zachou K, Youinou P (2007) Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis. Clin Rev Allergy Immunol, In press

  127. Rhiannon J (2007) Systemic lupus erythematosus involving the nervous system: Presentation, pathogenesis and management. Clin Rev Allergy Immunol, In press

  128. Witte T (2007) IgM antibodies against dsDNA in SLE. Clin Rev Allergy Immunol, In press

  129. Martin P, Malizia A, Rewald E (2007) A propos time and autoimmunity. Clin Rev Allergy Immunol, In press

  130. Ozcelik T (2007) X-chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol, In press

  131. Uz E, Loubiere L, Gadi V, Ozbalkan Z, Stewart J, Nelson J, et al (2007) Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol, In press

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yaniv Sherer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherer, Y., Matthias, T. & Shoenfeld, Y. Cutting Edge Issues in Autoimmunity. Clinic Rev Allerg Immunol 34, 275–278 (2008). https://doi.org/10.1007/s12016-007-8047-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-007-8047-9

Keywords

Navigation